BMS executive changes
This article was originally published in The Rose Sheet
Executive Summary
Peter Dolan appointed president of Bristol-Myers Squibb, responsible for the company's global medicines, beauty care and nutritionals businesses, BMS announces Jan. 20. Dolan, 44, reports to Chairman and CEO Charles Heimbold. Previously, Dolan was BMS senior VP-strategy and organizational effectiveness. He has experience in each of Bristol's four product categories, including personal care. Dolan's appointment is one of a number of executive promotions, including exec VP Donald Hayden, who is charged with implementing BMS' Internet strategy. Beauty Care and Nutritionals President Stephen Sadove remains in his current position and will assist Hayden on Web activities
|
Peter Dolan appointed president of Bristol-Myers Squibb, responsible for the company's global medicines, beauty care and nutritionals businesses, BMS announces Jan. 20. Dolan, 44, reports to Chairman and CEO Charles Heimbold. Previously, Dolan was BMS senior VP-strategy and organizational effectiveness. He has experience in each of Bristol's four product categories, including personal care. Dolan's appointment is one of a number of executive promotions, including exec VP Donald Hayden, who is charged with implementing BMS' Internet strategy. Beauty Care and Nutritionals President Stephen Sadove remains in his current position and will assist Hayden on Web activities. |